Basis: latest reported fiscal quarter (Q2 FY2025). Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly revenue is $20.05M with QoQ Growth of (10.34%). Quarterly revenue is the total sales generated during the latest fiscal quarter.
Reported quarterly revenue; no daily interpolation. Q2 FY2025 (2025-06-30): $20.05M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:51:41.656Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:51:41.656Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Period | Quarterly Revenue | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2025Period end 2025-06-30 | $20.05M | (10.34%) | (17.84%) |
| Q1 FY2025Period end 2025-03-31 | $22.37M | (28.15%) | (9.55%) |
| Q4 FY2024Period end 2024-12-31 | $31.13M | +33.85% | +41.83% |
| Q3 FY2024Period end 2024-09-30 | $23.26M | (4.72%) | +24.62% |
| Q2 FY2024Period end 2024-06-30 | $24.41M | (1.29%) | +22.45% |
| Q1 FY2024Period end 2024-03-31 | $24.73M | +12.66% | +41.85% |
| Q4 FY2023Period end 2023-12-31 | $21.95M | +17.61% | +31.63% |
| Q3 FY2023Period end 2023-09-30 | $18.66M | (6.38%) | +59.62% |
| Q2 FY2023Period end 2023-06-30 | $19.93M | +14.35% | N/A |
| Q1 FY2023Period end 2023-03-31 | $17.43M | +4.54% | N/A |
| Q4 FY2022Period end 2022-12-31 | $16.68M | +42.63% | N/A |
| Q3 FY2022Period end 2022-09-30 | $11.69M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.